People: China Pharma Holdings Inc (CPHI.A)
CPHI.A on American Stock Exchange
0.23USD
24 May 2013
0.23USD
24 May 2013
Price Change (% chg)
$0.02 (+7.34%)
$0.02 (+7.34%)
Prev Close
$0.21
$0.21
Open
$0.23
$0.23
Day's High
$0.23
$0.23
Day's Low
$0.21
$0.21
Volume
700
700
Avg. Vol
7,346
7,346
52-wk High
$0.55
$0.55
52-wk Low
$0.18
$0.18
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Zhilin Li |
59 | 2010 | Chairman of the Board, President, Chief Executive Officer |
Frank Waung |
47 | 2009 | Chief Financial Officer |
Heung Mei Tsui |
55 | 2009 | Director |
Gene Bennett |
64 | 2008 | Independent Director |
Baowen Dong |
71 | 2008 | Independent Director |
Yingwen Zhang |
67 | 2008 | Independent Director |
Biographies
| Name | Description |
|---|---|
Zhilin Li |
Ms. Zhilin Li is Chairman of the Board, President, Chief Executive Officer of China Pharma Holdings, Inc. She has served as a director since 2006 and as the President and Chief Executive Officer since 2005. She was a founder of Helpson, and served as hairman and Chief Executive Officer of Helpson from 1993 to 2005. Ms. Li was formerly the president of Haikou Bio-Engineering Institute as well as the vice president of Sichuan Institute of Biology. She graduated from Sichuan University with a degree in biology. |
Frank Waung |
Mr. Frank Waung is Chief Financial Officer of China Pharma Holdings, Inc. Mr. Waung currently also serves as a director of China Natural Gas (Nasdaq: CHNG). Mr. Waung worked for Hickey Freihofner Capital as an investment banker with a focus in China from 2008 until April 2009. Mr. Waung worked for Dellacamera Capital Management as a special situation analyst in 2007. Additionally, Mr. Waung acted as a convertible security trader from 2003 to 2006 and as a senior market economist at Cowen & Co. from 2000 to 2003. He worked for Credit Suisse First Boston as a quantitative marketer from 1994 to 1998. Mr. Waung received his master’s degree in business administration from University of Pennsylvania in 1994, and received his bachelor’s degree from University of California in 1988. |
Heung Mei Tsui |
Ms. Heung Mei Tsui is Director of China Pharma Holdings, Inc. Previously, Ms. Tsui served as a member of the board from October 2005 to February 2008. Ms. Tsui has been a self-employed businesswoman engaged in strategic investments and was previously engaged in the pharmaceutical chemical raw material import/export business. Ms. Tsui graduated from Hunan Financial & Economic College in 1982. |
Gene Bennett |
Mr. Gene Michael Bennett is Independent Director of China Pharma Holdings, Inc. In addition, he is on the Board of Directors for China Agritech, Inc. (CAGC) and Audit Committee Chair for Global Pharm Holding Group (GPHG). Mr. Bennett also presently serves as Chief Executive Officer of the American General Business Association in Beijing, China, since 2009. Mr. Bennett was a partner of Nexis Investment Consulting Corporation based in Beijing from 2004-2009. He acted as a partner of ProCFO Company based in California which provided contract chief financial officer service for firms during 2000-2004. During 1998-2000, he was a basic law, accounting and tax professor at University of Hawaii, and an accounting, tax and audit professor at Chaminade of Honolulu. He also previously served as the chief financial officer and member of the board of directors of Argonaut Computers in Southern California. Mr. Bennett worked as an accounting and audit professor at Chapman University. Mr. Bennett also worked as an accounting, tax, and audit professor at California State University at Fullerton, and he acted as chief financial officer and a board member of the National Automobile Club. Mr. Bennett graduated from Michigan State University with an MBA in Finance and BA in Accounting. He currently is a DBA candidate in Corporate Governance at City University of Hong Kong. Mr. Bennett obtained his CPA license from the State of Colorado, but is currently inactive. |
Baowen Dong |
Mr. Baowen Dong is Independent Director of China Pharma Holdings, Inc. Mr. Dong participated on the team of the Sichuan University from 2003 to 2008, doing teaching evaluation and assessment work in Engineering and Medical Science faculty. In recent years, Mr. Dong has focused on the research of China's Health Care Reform. Previously, he concentrated on biomedical and medical information researches. Mr. Dong has had different roles in areas of teaching and research, including as a dean and a professor, at Sichuan University from 1974 to 2001. Additionally, Mr. Dong was engaged in the field of communication technology from 1966 to 1974. Mr. Dong graduated from Xi’an University of Science and Technology in 1966. |
Yingwen Zhang |
Mr. Yingwen Zhang is Independent Director of China Pharma Holdings, Inc. He also currently serves as the Vice-Chairman of the Board of Shanghai Reseat Medical Tech Co. Ltd., a medical device producer. Mr. Zhang is also a director and a member of the compensation committee of Chongqing Wanli Battery Holdings (Group) LLC (SHA:600847). He acted as Senior Consultant and Chairman of Safety Production Committee of Sinofert Holdings Limited (HKG: 0297) of Sinochem Group from October 2005 to June 2009. Additionally, Mr. Zhang was the representative of the 9th Nation People’s Congress of China. He was also appointed as the Commercial Counselor of the China Embassy in Malaysia from March 2000 through October 2005. Prior to that, Mr. Zhang was appointed as the Director-General to Sichuan Provincial Foreign Trade and Economic Cooperation Bureau (the Commercial Bureau of Sichuan Province, China) from 1988 to 2000. In his early career he was a chemical-engineer, and then became a senior manager for several chemical corporations in China. From 1983 to 1988, Mr. Zhang served as the Chief Executive Officer of a nature gas-chemical state owned enterprise (SOE) in the PRC affiliated with the Sinopec Group. Mr. Zhang graduated from the Chemical Engineering Department of Tianjin University in 1967. |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Zhilin Li |
322,945 |
Frank Waung |
269,238 |
Heung Mei Tsui |
6,002 |
Gene Bennett |
-- |
Baowen Dong |
-- |
Yingwen Zhang |
-- |
As Of 30 Dec 2011
Options Compensation
| Name | Options | Value |
|---|---|---|
Zhilin Li |
0 | 0 |
Frank Waung |
0 | 0 |
Heung Mei Tsui |
0 | 0 |
Gene Bennett |
0 | 0 |
Baowen Dong |
0 | 0 |
Yingwen Zhang |
0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
WAUNG FRANK |
100,000 | $0.00 |
WAUNG FRANK |
100,000 | $0.00 |

